Drug Trial Radar · NCT03228680
Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Japanese Women
Last checked: Nov 19, 2026Latest source record: Aug 24, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
373
Actual
Start
Jul 29, 2017
Primary completion
Jun 10, 2019
Study completion Jul 8, 2019
Sponsor
- Lead sponsor
- Ferring PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Jul 25, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 20 years, up to 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To demonstrate non-inferiority of FE 999049 compared to FOLLISTIM with respect to number of oocytes retrieved in Japanese IVF/ICSI patients undergoing controlled ovarian stimulation.
Conditions
- Infertility
Interventions
Follitropin deltaDrug
Single daily subcutaneous administration through pre-filled injection pen
Follitropin betaDrug
Single daily subcutaneous injection in the abdomen
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Oocytes RetrievedTime frame: 36h (± 2h) after triggering of final follicular maturation (On day of oocyte retrieval)
Locations
17 sites in 1 country. Site status is shown where the registry gives one.
Akita University Hospital
Akita, Japan
Yamashita Ladies' Clinic
Hyōgo, Japan
Investigational Site 8126
Saitama, Japan
Omiya Ladies Clinic
Saitama, Japan
Saint Women's Clinic
Saitama, Japan
Women's Clinic Fujimino
Saitama, Japan
Tokushima University Hospital
Tokushima, Japan
Yachiyo Hospital
Anjo, Aichi-ken, Japan
Investigational Site 8121
Chiba, Chiba, Japan
Yokota Maternity Hospital
Maebashi, Gunma, Japan
Sophia Ladies Clinic
Sagamihara, Kanagawa, Japan
Investigational Site 8122
Sendai, Miyagi, Japan
Investigational Site 8123
Higashiōsaka-shi, Osaka, Japan
Investigational Site 8120
Osaka, Osaka, Japan
Ladies Clinic Kitahama
Osaka, Osaka, Japan
Investigational Site 8125
Saitama-shi, Saitama, Japan
Investigational Site 8124
Shinjuku-Ku, Tokyo, Japan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.